Nemaura Medical Inc.
OTC: NMRD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dewan Fazlul Hoque Chowdhury
- Employees
- 36
- Headquarters
- New York City, United States
- IPO year
- 2018
- Market cap
- $4.0K
- Website
- https://nemauramedical.com
Loading NMRD…
Loading profile data…Frequently asked questions about NMRD
What does Nemaura Medical Inc. (NMRD) do?
Nemaura Medical Inc. is a medical technology company dedicated to inventing, developing, and bringing to market diagnostic medical devices. Its flagship product, sugarBEAT, is an innovative, non-invasive continuous glucose monitoring (CGM) system. This device is designed to assist individuals with Type 1 and Type 2 diabetes in managing their con...
Where does NMRD trade?
Nemaura Medical Inc. (NMRD) trades on the Other OTC.
What sector is NMRD in?
Nemaura Medical Inc. (NMRD) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Nemaura Medical Inc.?
Dewan Fazlul Hoque Chowdhury is the chief executive officer of Nemaura Medical Inc. (NMRD).
Where is Nemaura Medical Inc. headquartered?
Nemaura Medical Inc. is headquartered in United States.
Does NMRD pay a dividend?
Nemaura Medical Inc. (NMRD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NMRD go public?
Nemaura Medical Inc. (NMRD) completed its initial public offering in 2018.